Anne Kirsten

3.8k total citations · 2 hit papers
35 papers, 2.6k citations indexed

About

Anne Kirsten is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Complementary and alternative medicine. According to data from OpenAlex, Anne Kirsten has authored 35 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 12 papers in Physiology and 4 papers in Complementary and alternative medicine. Recurrent topics in Anne Kirsten's work include Chronic Obstructive Pulmonary Disease (COPD) Research (30 papers), Asthma and respiratory diseases (11 papers) and Respiratory Support and Mechanisms (9 papers). Anne Kirsten is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (30 papers), Asthma and respiratory diseases (11 papers) and Respiratory Support and Mechanisms (9 papers). Anne Kirsten collaborates with scholars based in Germany, United Kingdom and Belgium. Anne Kirsten's co-authors include Henrik Watz, H Magnussen, Benjamin Waschki, Olaf Holz, Thorsten Meyer, Kai-Christian Müller, Gunther Kretschmar, Kay Tetzlaff, Peter M.A. Calverley and Bernd Disse and has published in prestigious journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Anne Kirsten

35 papers receiving 2.5k citations

Hit Papers

Physical Activity Is the Strongest Predictor of All-Cause... 2011 2026 2016 2021 2011 2014 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Physical Activity Is the Strongest Predictor of All-Cause Mortality in Patients With COPD
    2011 708 citations Benjamin Waschki, Anne Kirsten et al. CHEST Journal profile →
  2. Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
    2014 406 citations H Magnussen, Bernd Disse et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Kirsten Germany 18 2.3k 1.2k 316 247 160 35 2.6k
Benjamin Waschki Germany 22 2.7k 1.2× 1.2k 1.0× 445 1.4× 443 1.8× 276 1.7× 55 3.1k
Timothy Griffiths United Kingdom 10 1.4k 0.6× 460 0.4× 337 1.1× 204 0.8× 179 1.1× 19 1.8k
J Kraan Netherlands 18 1.5k 0.7× 865 0.7× 152 0.5× 171 0.7× 70 0.4× 39 1.9k
Marina Aiello Italy 24 1.2k 0.5× 619 0.5× 217 0.7× 247 1.0× 96 0.6× 91 1.9k
Michael Tamm Switzerland 24 1.6k 0.7× 646 0.5× 271 0.9× 49 0.2× 301 1.9× 91 2.0k
S. I. Rennard United States 13 1.6k 0.7× 719 0.6× 198 0.6× 39 0.2× 160 1.0× 17 1.8k
Andrea Zanini Italy 20 1.1k 0.5× 785 0.6× 118 0.4× 131 0.5× 98 0.6× 38 1.8k
Justin Travers New Zealand 20 1.4k 0.6× 1.1k 0.9× 73 0.2× 67 0.3× 84 0.5× 36 1.7k
Diego A. Rodríguez Spain 22 1.1k 0.5× 595 0.5× 233 0.7× 204 0.8× 93 0.6× 88 1.6k
M. Decramer Belgium 13 1.3k 0.6× 551 0.4× 127 0.4× 292 1.2× 52 0.3× 15 1.5k

Countries citing papers authored by Anne Kirsten

Since Specialization
Citations

This map shows the geographic impact of Anne Kirsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Kirsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Kirsten more than expected).

Fields of papers citing papers by Anne Kirsten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Kirsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Kirsten. The network helps show where Anne Kirsten may publish in the future.

Co-authorship network of co-authors of Anne Kirsten

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Kirsten. A scholar is included among the top collaborators of Anne Kirsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Kirsten. Anne Kirsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weber, Melanie, Thomas Bahmer, Frauke Pedersen, et al.. (2020). Exploration of the sputum methylome and omics deconvolution by quadratic programming in molecular profiling of asthma and COPD: the road to sputum omics 2.0. Respiratory Research. 21(1). 274–274. 12 indexed citations
2.
Watz, Henrik, Johannes Nagelschmitz, Anne Kirsten, et al.. (2019). Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial. Pulmonary Pharmacology & Therapeutics. 56. 86–93. 54 indexed citations
3.
Greulich, Timm, Jens M. Hohlfeld, Petra Neuser, et al.. (2018). A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial. Respiratory Research. 19(1). 55–55. 34 indexed citations
4.
5.
Waschki, Benjamin, Anne Kirsten, Olaf Holz, et al.. (2015). Disease Progression and Changes in Physical Activity in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 192(3). 295–306. 179 indexed citations
6.
Pedersen, Frauke, Sebastian Marwitz, Olaf Holz, et al.. (2015). Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients. Respiratory Medicine. 109(10). 1360–1362. 68 indexed citations
7.
Esser, Roland W., M. Cornelia Stoeckel, Anne Kirsten, et al.. (2015). Structural Brain Changes in Patients With COPD. CHEST Journal. 149(2). 426–434. 54 indexed citations
8.
Waschki, Benjamin, Anne Kirsten, Olaf Holz, et al.. (2015). The role of sustained physical inactivity in the progression of exercise intolerance and muscle depletion in COPD. Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft). PA3550–PA3550. 1 indexed citations
9.
Watz, Henrik, Johannes Nagelschmitz, Frauke Pedersen, et al.. (2014). Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum. European Respiratory Journal. 44(Suppl 58). P2049–P2049. 2 indexed citations
10.
Magnussen, H, Bernd Disse, Roberto Rodríguez-Roisin, et al.. (2014). Exacerbation Risk Is Not Worse When ICS Are Withdrawn in a Stepwise Manner in Severe to Very Severe COPD Patients Receiving LAMA+LABA: The WISDOM Study. CHEST Journal. 146(4). 63A–63A. 2 indexed citations
11.
Magnussen, H, Bernd Disse, Roberto Rodríguez-Roisin, et al.. (2014). The Impact of Stepwise Withdrawal of ICS on FEV1, mMRC, and SQRQ in Severe to Very Severe COPD Patients Treated With LAMA+LABA: The WISDOM Study. CHEST Journal. 146(4). 76A–76A. 2 indexed citations
12.
Magnussen, H, Henrik Watz, Anne Kirsten, et al.. (2014). Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale. Respiratory Medicine. 108(4). 593–599. 30 indexed citations
13.
14.
15.
Waschki, Benjamin, Anne Kirsten, Olaf Holz, et al.. (2011). Physical Activity Is the Strongest Predictor of All-Cause Mortality in Patients With COPD. CHEST Journal. 140(2). 331–342. 708 indexed citations breakdown →
16.
Watz, Henrik, Daniel Bock, Michael C. Meyer, et al.. (2011). Late-breaking abstract: Inhaled pan-selectin antagonist bimosiamose in COPD: A double-blind, randomized, placebo-controlled phase II study. European Respiratory Journal. 38(Suppl 55). 4492–4492. 2 indexed citations
17.
Magnussen, H, Henrik Watz, Anne Kirsten, et al.. (2011). Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: A randomised controlled 6-week trial. Pulmonary Pharmacology & Therapeutics. 24(5). 563–570. 26 indexed citations
18.
Kirsten, Anne, Henrik Watz, Gunther Kretschmar, et al.. (2011). Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects – A double blind, randomized, placebo-controlled, cross-over clinical trial. Pulmonary Pharmacology & Therapeutics. 24(5). 555–558. 24 indexed citations
19.
Watz, Henrik, Benjamin Waschki, Gunther Kretschmar, et al.. (2010). Decreasing Cardiac Chamber Sizes and Associated Heart Dysfunction in COPD. CHEST Journal. 138(1). 32–38. 204 indexed citations
20.
Watz, Henrik, Benjamin Waschki, Anne Kirsten, et al.. (2009). The Metabolic Syndrome in Patients With Chronic Bronchitis and COPD. CHEST Journal. 136(4). 1039–1046. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Waschki Breakdown of academic impact, for papers by Timothy Griffiths Breakdown of academic impact, for papers by J Kraan Breakdown of academic impact, for papers by Marina Aiello Breakdown of academic impact, for papers by Michael Tamm Breakdown of academic impact, for papers by S. I. Rennard Breakdown of academic impact, for papers by Andrea Zanini Breakdown of academic impact, for papers by Justin Travers Breakdown of academic impact, for papers by Diego A. Rodríguez Breakdown of academic impact, for papers by M. Decramer
Rankless by CCL
2026